Serum Life Sciences will make an additional equity investment of $150 million in Biocon's subsidiary Biocon Biologics (BBL) under a new arrangement, Biocon announced in a filing to exchanges.
BBL and Serum Institute of Life Sciences (SILS) have reached …
VIEW ARTICLE
If you would like to know more regarding the topic in this blog post, please do not hesitate to contact us.
